Status:
UNKNOWN
Urethral Stricture After Transurethral Resection of the Prostate/Bladder: a Prospective Study of Risk Factors
Lead Sponsor:
University Hospital Virgen de las Nieves
Collaborating Sponsors:
Instituto de Investigación Biosanitaria de Granada (ibs.Granada)
Conditions:
Urethral Stricture, Male
Hormone Deficiency
Eligibility:
MALE
18+ years
Brief Summary
There is currently no prognostic or predictive risk marker for this urethral stricture disease. The most conservative standard treatment for urethral stricture (internal urethrotomy) has a very high ...
Detailed Description
The pathophysiological mechanisms that influence the development of urethral stricture are not established. In developed countries, the most common etiology of urethral stricture is idiopathic (41%) f...
Eligibility Criteria
Inclusion
- Patients undergoing transurethral resection of the prostate or bladder (TUR P/B) at our department.
Exclusion
- Patients not giving their informed consent
- Patients with urethral catheter at the moment of TUR P/B
- Patients with any type of urethral stricture at the moment of TUR P/B
- Patients under hormonal treatments (testosterone, thyroxine...) 1 year before the TUR P/B.
- Patients with already known coagulation disorders or undergoing anticoagulation treatments at the moment of the blood test.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04795570
Start Date
September 1 2020
End Date
September 1 2022
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen de las Nieves
Granada, Spain, 18003